A slim majority of FDA advisory panelists rejected that the benefits of a radiofrequency renal denervation system outweigh the risks for use in adults with uncontrolled hypertension despite use of antihypertensive medications.\n\n https://yamcode.com/macron-says-wants-update-2242-09202023-233926 https://yamcode.com/raw/macron-says-wants-update-2242-09202023-233926